Role of<i>O</i>-linked<i>N</i>-acetylglucosamine modification in diabetic nephropathy
Renáta Gellai(Semmelweis University), Andrea Fekete(Semmelweis University)
Cited by 53
Related Papers
RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition
|The Journal of Physiology|2018|95
Reduced <i>O</i>-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney
|American Journal of Physiology-Renal Physiology|2020|51